This Key Event Relationship is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Relationship: 3228
Title
Reduction, DHEA leads to Decrease, circulating testosterone levels
Upstream event
Downstream event
Key Event Relationship Overview
AOPs Referencing Relationship
| AOP Name | Adjacency | Weight of Evidence | Quantitative Understanding | Point of Contact | Author Status | OECD Status |
|---|---|---|---|---|---|---|
| Inhibition of 17α-hydrolase/C 10,20-lyase (Cyp17A1) activity leads to birth reproductive defects (cryptorchidism) in male (mammals) | adjacent | High | High | Bérénice COLLET (send email) | Open for citation & comment |
Taxonomic Applicability
| Term | Scientific Term | Evidence | Link |
|---|---|---|---|
| mammals | mammals | High | NCBI |
Sex Applicability
| Sex | Evidence |
|---|---|
| Mixed | High |
Life Stage Applicability
| Term | Evidence |
|---|---|
| All life stages | High |
Key Event Relationship Description
This KER refers to part of steroidogenesis that includes the effects of decreased dehydroepiandrosterone (DHEA) levels that can lead to decreased testosterone levels. DHEA is converted to testosterone via one of the intermediates androstenedione or androstenediol by 3-beta-hydroxysteroid dehydrogenase (3-beta-HSD) and 17-beta-hydroxysteroid dehydrogenase (17-beta-HSD). Therefore, effects on DHEA levels can have downstream effects on testosterone levels (Flück, 2017; Naamneh Elzenaty, 2022).
Evidence Collection Strategy
The KER describes a generally recognized and understood process, i.e. canonical knowledge. The aim of the literature search was therefore to identify review articles and book chapters that summarise the canonical knowledge. PubMed was searched using key words related to steroidogenesis. The search was restricted to reviews from the last 10 years.
Evidence Supporting this KER
Biological Plausibility
It is well established that DHEA is a precursor for testosterone (Flück, 2017; Naamneh Elzenaty, 2022).
Testosterone is produced in human Leydig cells from DHEA via androstenedione or androstenediol by the enzymes 3-beta-hydroxysteroid dehydrogenase (3-beta-HSD) and 17-beta-hydroxysteroid dehydrogenase (17-beta-HSD). Testosterone is also synthesized from DHEA in human theca cells (Flück, 2017; Naamneh Elzenaty, 2022).
As DHEA is a precursor of testosterone, any effect on DHEA levels is expected to impact testosterone as well.
Empirical Evidence
Exposure to stressors can lead to a decrease of DHEA that in turn leads to decrease of downstream hormones like testosterone.
Using H295R cells, exposure of ketoconazole resulted in a dose-dependent decreased in the levels of DHEA and testosterone (Nielsen et al., 2012). This was also observed using fluconazole on both H295R cells and its clonal cell line, HAC15 (van der Pas et al., 2012).
In female individuals with decreased libido, reduced levels of DHEA-sulfate, which represents a reservoir pool of DHEA, and testosterone have been observed (Guay et al., 2002). Oral supplementation with DHEA restores testosterone levels (Li etal., 2020; Liu et al., 2013).
Uncertainties and Inconsistencies
Known modulating factors
Quantitative Understanding of the Linkage
Response-response Relationship
Time-scale
Known Feedforward/Feedback loops influencing this KER
Domain of Applicability
Taxonomic applicability.
This KER is applicable to mammals, but DHEA from the Δ5 pathway is a precursor for testosterone mainly in humans, whereas in rodents the Δ4 pathway instead produces 17-OH-progesterone as the main precursor for testosterone (Flück, 2017; Naamneh Elzenaty, 2022).
Life stage applicability
DHEA is synthesized in the fetus and adult (Flück, 2017; Naamneh Elzenaty, 2022).
Sex applicability
Testosterone is synthesised from DHEA in both sexes, although at lower levels in females (Naamneh Elzenaty, 2022).
References
Flück CE & Pandey AV (2017). Testicular Steroidogenesis. In Simoni, M & Huhtaniemi IT (Eds.) Endocrinology of the Testis and Male Reproduction. (1st ed., pp. 343-371) Endocrinology. Cham: Springer International Publishing. https://doi.org/10.1007/978-3-319-44441-3.
Guay AT, Jacobson J. Decreased free testosterone and dehydroepiandrosterone-sulfate (DHEA-S) levels in women with decreased libido. J Sex Marital Ther. 2002;28 Suppl 1:129-42. doi: 10.1080/00926230252851258. PMID: 11898695.
Li Y, Ren J, Li N, Liu J, Tan SC, Low TY, Ma Z. A dose-response and meta-analysis of dehydroepiandrosterone (DHEA) supplementation on testosterone levels: perinatal prediction of randomized clinical trials. Exp Gerontol. 2020 Nov;141:111110. doi: 10.1016/j.exger.2020.111110. Epub 2020 Oct 10. PMID: 33045358.
Liu TC, Lin CH, Huang CY, Ivy JL, Kuo CH. Effect of acute DHEA administration on free testosterone in middle-aged and young men following high-intensity interval training. Eur J Appl Physiol. 2013 Jul;113(7):1783-92. doi: 10.1007/s00421-013-2607-x. Epub 2013 Feb 17. PMID: 23417481.
Naamneh Elzenaty R, du Toit T, and Flück CE. 2022. ‘Basics of Androgen Synthesis and Action.’ Best Practice & Research. Clinical Endocrinology & Metabolism 36 (4): 101665. https://doi.org/10.1016/j.beem.2022.101665.
Nielsen, F. K., Hansen, C. H., Fey, J. A., Hansen, M., Jacobsen, N. W., Halling-Sørensen, B., Björklund, E., & Styrishave, B. (2012). H295R cells as a model for steroidogenic disruption: A broader perspective using simultaneous chemical analysis of 7 key steroid hormones. Toxicology in Vitro, 26(2), 343–350. https://doi.org/10.1016/j.tiv.2011.12.008
van der Pas, R., Hofland, L. J., Hofland, J., Taylor, A. E., Arlt, W., Steenbergen, J., van Koetsveld, P. M., de Herder, W. W., de Jong, F. H., & Feelders, R. A. (2012). Fluconazole inhibits human adrenocortical steroidogenesis in vitro. Journal of Endocrinology, 215(3), 403–412. https://doi.org/10.1530/JOE-12-0310